Welcome to ActionLyme - the Lyme Cryme Whistleblower's Website

IDSA's Secrets:
IDSA's Treatment Failures

USDOJ RICO filed "Cryme Disease" book Bioweapons Attributes
(See Israeli section)

Pam3Cys Imitators/AIDS

PubMed: TLR2

"New World Disorder"
Relapsing Fever History Dearborn Booklet (pdf) Chp 1 Scientific Validity ALDF/IDSA's RICO Patents Osp-A/Viral Synergy Grants Search "TLR2" Kissinger NWO Beast
IDSA's Great Imitators Dearborn Quotes Chp 2 McSweegan Corixa-Imugen RICO "LYMErix ▲ Disease" Myco & Erythrocytes Rx Brain Damage
Steere Falsifies Lyme Test UConn's Kid Tuskegee Falsified Vax & FDA CDCs Patents w/SKB Pam3Cys_ImmuSupp GarthNicolson-GWI Rockefeller/Psychiatry
IDSA's Biomarkers Schoen-LYMErix Plum Island (Fish, Radolf) DARPA Boots CDC Confronting NIH CT Med Board Hell/NDEs
Klempner's Crimes Weinstein's Frauds Russians & NYMC Auwaerter EBV NIH Disinfo Foreign CPS' Sexual Assaults
IDSA: "Cyst Viable" Yale's Valid Test Yale Congen Lyme Reports  Plum Stupid Vaccines' Brain Damage Fraud With Intent   CPS' Entrapment
DNA/RNA ShellGame Not used for LYMErix Why do "Jews" hate us?
It's in the Talmud.
IDSA ▲ self-indicts
Durland Fish the Gangster
Dancing Queen

Update on Sex Abuse

04/14/2014 15:27:14


The fake Lyme,  Dearborn,Vaccines Scam; What really happened.

CrymeTrainer; Outline for Indictments

Non-HLA-linked diseases = Mold-Related illnesses (like LYMErix-Disease, Lyme, CFIDS/FM, and Gulf War Illness)

Fauci's Patent for MS Tmt is for LYMErix-Disease.

Vaccinetoons=Mayo Clinic (hilarious)

Follow the Scam in the order it occurred, below:

Older data on the incurability of Relapsing Fever

1986, McSweegan trashes Navy for $$$ for ALDF.com

1988, Dattwyler & about immune-suppressing, seronegative Lyme

1990, CDC: "Diagnose Lyme as if it was Relapsing Fever."

Allen Steere  "NeuroLyme won't test positive," 1990.

1992, CDC officer Allen Steere falsifies testing in Europe

1992, CDC patents with SmithKline show 2 kinds of Lyme

1993, Barbour and Fish slam Neurologic Lyme victims.

Compare the 2 kinds of Lyme in the RICO complaint

1994, FDA LYMErix Meeting

1994, CDC's Dearborn Booklet .pdf

CDC's invitation to participate in Dearborn .pdf

Dearborn, Who Said What?

Igenex, Harris, Dearborn .pdf

Evidence  Lyme criminals knew LYMErix produced the same "multisystem disease" as "Chronic Lyme"

LYMErix Damage Coverup (short)

120302 NIH Treatments

1998, CIA Oilmen & Israelis plan to overthrow Saddam for the oil.

ActionLyme/Kathleen Dickson predicts all of Bushie's outcomes in Oct 2000

ActionLyme/Kathleen Dickson predicts Bush will have us worshipping his bombs (Shock and Awe"), in Oct 2000 during the Gore Debates

Steere's "Seronegative Lyme" Hysteria about OspA-induced Antibody Inhibition
Read about it also in the 1998 FDA LYMErix meeting transcript:

; Steere using Dattwyler and Volkman's Seronegative Lyme Assay (developed because Dattwyler knew fungal antigens produced immunosuppression) to evaluate "Chronic Neurologic Lyme" cases:


See Also, CRYMEDISEASE_CHP3_B.htm  where we show Steere in 1991 actually used this seronegative Lyme assay on his own lab
workers, 101016.htm (
http://www.ncbi.nlm.nih.gov/pubmed/1883122)  where we see Steere knowingly falsely advising the Academy
of Insurance Medicine a year later (1992), and the Plum Island Chapter of Cryme Disease where Justin Radolf demonstrates in 2001
that OspA vaccination (or autovaccination via blebbing), results in inhibition of antibody production via downregulation of HLA.

N  1988 Dec 1;319(22):1441-6.

Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi.


Department of Medicine, State University of New York, School of Medicine, Stony Brook 11794-8161.


The diagnosis of Lyme disease often depends on the measurement of serum antibodies to Borrelia burgdorferi, the spirochete that causes this disorder. Although prompt treatment with antibiotics may abrogate the antibody response to the infection, symptoms persist in some patients. We studied 17 patients who had presented with acute Lyme disease and received prompt treatment with oral antibiotics, but in whom chronic Lyme disease subsequently developed. Although these patients had clinically active disease, none had diagnostic levels of antibodies to B. burgdorferi on either a standard enzyme-linked immunosorbent assay or immunofluorescence assay. On Western blot analysis, the level of immunoglobulin reactivity against B. burgdorferi in serum from these patients was no greater than that in serum from normal controls. The patients had a vigorous T-cell proliferative response to whole B. burgdorferi, with a mean ( +/- SEM) stimulation index of 17.8 +/- 3.3, similar to that (15.8 +/- 3.2) in 18 patients with chronic Lyme disease who had detectable antibodies. The T-cell response of both groups was greater than that of a control group of healthy subjects (3.1 +/- 0.5; P less than 0.001). We conclude that the presence of chronic Lyme disease cannot be excluded by the absence of antibodies against B. burgdorferi and that a specific T-cell blastogenic response to B. burgdorferi is evidence of infection in seronegative patients with clinical indications of chronic Lyme disease.

Comment in